Member of Lyonbiopole
Founded in early 2005 by a group of senior managers with extensive drug discovery expertise gained in Life-Science organizations, Edelris is a privately-owned research and services company offering original natural product-like collections of screening compounds, innovative fragments for FBLD and efficient Hit to Lead and Lead optimisation capabilities.
Recent publications:
Co-authored with Bayer: Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
Co-authored with Nestlé Skin Health: New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space
Strategic application domain: Human Medicine
Application market: Infectious Diseases, Oncology, Others
Type of activity: CRO - Tools - R&D platform, Technology provider
Technologies: Chemical synthesis services & medicinale chemistry, Screening methods or services, Small Molecules
Created on feb. 14th, 2005 - 60 employees
Address
60, Avenue Rockefeller, Bioparc, Bioserra 1 Building 69008 Lyon
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.